Skip to main content
. Author manuscript; available in PMC: 2015 Jul 1.
Published in final edited form as: Arthritis Care Res (Hoboken). 2014 Jul;66(7):1063–1072. doi: 10.1002/acr.22259

Figure 1. Step Up Strategy CTP.

Figure 1

Non-biologic DMARD at treatment initiation followed by the option to start a biologic DMARD at 3 months or thereafter based on clinical assessment. DMARD= non-biologic DMARD; biologic= biologic DMARD; IAS= intraarticular glucocorticoid injection. DMARD choices include methotrexate, leflunomide, and sulfasalazine. Biologic choices include any inhibitor of TNF, T cell co-stimulation, IL6 or B cells.